Cargando…
Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
We report a case of a 73-year-old man diagnosed with pulmonary pleomorphic carcinoma who showed profound durable response after a single treatment with pembrolizumab. The patient underwent a diagnostic workup in our hospital due to a hoarseness of voice. Chest computed tomography revealed a massive...
Autores principales: | Tokuyasu, Hirokazu, Ishikawa, Soichiro, Sakai, Hiromitsu, Ikeuchi, Tomoyuki, Miura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586952/ https://www.ncbi.nlm.nih.gov/pubmed/31249776 http://dx.doi.org/10.1016/j.rmcr.2019.100879 |
Ejemplares similares
-
Multiple lung cancers including squamous cell carcinoma with strong PD-L1 expression and adenocarcinoma with EGFR exon 19 deletion: A case report
por: Tokuyasu, Hirokazu, et al.
Publicado: (2019) -
Successful Treatment of Lung Adenocarcinoma with Epidermal Growth Factor Receptor Compound Mutations Involving Exon 19 Deletion and Exon 20 Insertion by Afatinib
por: Ikeuchi, Tomoyuki, et al.
Publicado: (2019) -
A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer
por: Kondo, Yoshihiro, et al.
Publicado: (2022) -
Combination treatment with antibiotics and surgical lung resection for Mycobacterium abscessus pulmonary infection in a breast cancer patient
por: Tokuyasu, Hirokazu, et al.
Publicado: (2021) -
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
por: Chang, Hao‐Chun, et al.
Publicado: (2020)